See more : Glaukos Corporation (GKOS) Income Statement Analysis – Financial Results
Complete financial analysis of Azenta, Inc. (AZTA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Azenta, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Bonheur ASA (BONHR.OL) Income Statement Analysis – Financial Results
- Wai Chun Group Holdings Limited (1013.HK) Income Statement Analysis – Financial Results
- ERYTECH Pharma S.A. (ERYP.PA) Income Statement Analysis – Financial Results
- Tenax Therapeutics, Inc. (TENX) Income Statement Analysis – Financial Results
- Abacus Property Group (ABP.AX) Income Statement Analysis – Financial Results
Azenta, Inc. (AZTA)
About Azenta, Inc.
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold sample management systems for compound and biological sample storage; equipment for sample preparation and handling; consumables; and instruments that help customers in managing samples throughout their research discovery and development workflows. The Life Sciences Services segment provides comprehensive sample management programs, integrated cold chain solutions, informatics, and sample-based laboratory services to advance scientific research and support drug development. This segment's services include sample storage, genomic sequencing, gene synthesis, laboratory processing, laboratory analysis, biospecimen procurement, and other support services. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Chelmsford, Massachusetts.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 656.32M | 665.07M | 555.50M | 513.70M | 897.27M | 781.87M | 631.56M | 692.89M | 560.32M | 552.71M | 482.85M | 450.95M | 519.45M | 688.11M | 592.97M | 218.71M | 526.37M | 743.26M | 692.87M | 463.75M | 539.77M | 343.61M | 304.25M | 381.72M | 321.10M | 103.90M | 99.90M | 86.40M | 90.40M | 45.70M | 24.00M |
| Cost of Revenue | 392.96M | 401.93M | 299.91M | 269.89M | 517.25M | 465.11M | 385.48M | 425.48M | 362.24M | 363.60M | 315.51M | 304.97M | 345.97M | 465.08M | 426.68M | 224.70M | 399.54M | 523.66M | 448.09M | 300.94M | 335.45M | 239.94M | 221.21M | 229.33M | 159.66M | 47.80M | 64.30M | 53.60M | 49.50M | 26.10M | 14.20M |
| Gross Profit | 263.37M | 263.14M | 255.58M | 243.81M | 380.02M | 316.76M | 246.08M | 267.40M | 198.08M | 189.11M | 167.34M | 145.98M | 173.49M | 223.02M | 166.30M | -6.00M | 126.83M | 219.60M | 244.78M | 162.80M | 204.32M | 103.67M | 83.04M | 152.38M | 161.44M | 56.10M | 35.60M | 32.80M | 40.90M | 19.60M | 9.80M |
| Gross Profit Ratio | 40.13% | 39.57% | 46.01% | 47.46% | 42.35% | 40.51% | 38.96% | 38.59% | 35.35% | 34.21% | 34.66% | 32.37% | 33.40% | 32.41% | 28.04% | -2.74% | 24.10% | 29.54% | 35.33% | 35.11% | 37.85% | 30.17% | 27.29% | 39.92% | 50.28% | 53.99% | 35.64% | 37.96% | 45.24% | 42.89% | 40.83% |
| Research & Development | 33.53M | 33.96M | 27.54M | 22.41M | 59.06M | 56.37M | 46.94M | 47.00M | 51.54M | 52.23M | 52.65M | 48.99M | 47.46M | 39.85M | 31.16M | 31.61M | 42.92M | 51.72M | 70.67M | 62.77M | 67.13M | 72.89M | 75.06M | 60.87M | 42.95M | 22.40M | 22.70M | 14.20M | 12.40M | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 110.16M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 302.74M | 316.28M | 252.07M | 252.10M | 241.14M | 211.96M | 167.02M | 153.06M | 130.26M | 115.27M | 111.10M | 99.55M | 110.16M | 102.54M | 85.60M | 91.23M | 110.52M | 120.42M | 141.03M | 83.15M | 96.77M | 98.31M | 101.21M | 95.92M | 70.86M | 31.60M | 26.50M | 12.80M | 12.40M | 11.80M | 6.50M |
| Other Expenses | 127.78M | -13.97M | -266.00K | -16.48M | -1.39M | -1.46M | -3.30M | -645.00K | -579.00K | 421.00K | 256.00K | 1.23M | 15.24M | 1.04M | 2.53M | 99.19M | 203.57M | 7.11M | 5.30M | 3.10M | 3.66M | 44.61M | 499.57M | 30.19M | 30.21M | 10.40M | 8.10M | 4.80M | 3.10M | 1.20M | 800.00K |
| Operating Expenses | 468.00M | 336.27M | 279.61M | 274.51M | 300.20M | 268.33M | 213.96M | 200.07M | 181.80M | 167.50M | 163.75M | 148.54M | 157.62M | 142.39M | 116.76M | 122.84M | 357.01M | 172.14M | 211.70M | 149.02M | 167.56M | 215.81M | 675.83M | 186.97M | 144.02M | 64.40M | 57.30M | 31.80M | 27.90M | 13.00M | 7.30M |
| Cost & Expenses | 857.00M | 739.24M | 579.52M | 544.41M | 817.45M | 733.44M | 599.44M | 625.55M | 544.05M | 531.11M | 479.26M | 453.51M | 503.59M | 607.47M | 543.44M | 347.54M | 756.55M | 695.80M | 659.79M | 449.97M | 503.01M | 455.75M | 897.04M | 416.31M | 303.68M | 112.20M | 121.60M | 85.40M | 77.40M | 39.10M | 21.50M |
| Interest Income | 33.18M | 43.74M | 20.29M | 632.00K | 849.00K | 1.45M | 1.88M | 464.00K | 452.00K | 899.00K | 950.00K | 1.03M | 1.21M | 1.15M | 1.12M | 2.72M | 7.40M | 11.90M | 13.72M | 9.28M | 4.98M | 4.07M | 9.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 4.59M | 2.04M | 2.94M | 22.25M | 9.52M | 408.00K | 157.00K | 395.00K | 202.00K | 2.00K | 14.00K | 65.00K | 80.00K | 454.00K | 407.00K | 583.00K | 9.38M | 9.47M | 9.49M | 10.04M | 10.29M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 90.74M | 85.58M | 53.70M | 56.87M | 65.50M | 54.45M | 36.70M | 27.20M | 28.05M | 25.16M | 23.46M | 24.16M | 21.62M | 17.25M | 18.42M | 25.86M | 34.54M | 32.80M | 33.90M | 17.19M | 18.38M | 31.81M | 38.03M | 45.26M | 30.21M | 10.40M | 8.10M | 4.80M | 3.10M | 1.20M | 800.00K |
| EBITDA | 21.80M | 55.15M | 48.36M | 9.94M | 28.15M | 15.19M | 66.69M | 42.13M | 4.24M | 43.37M | 21.81M | 9.62M | 33.04M | 144.83M | 74.56M | -201.06M | -201.21M | 89.02M | 57.69M | 29.41M | 64.62M | -158.40M | -627.82M | 10.67M | 50.48M | 2.40M | -16.10M | 3.50M | 17.60M | 7.80M | 3.30M |
| EBITDA Ratio | 3.32% | 8.29% | 8.95% | 3.66% | 16.14% | 13.16% | 10.79% | 14.02% | 7.89% | 8.70% | 5.85% | 5.29% | 7.45% | 14.39% | 11.65% | -45.84% | 3.97% | 11.22% | 10.89% | 9.87% | 11.38% | -1.46% | -19.40% | 5.52% | 15.02% | 5.20% | -13.51% | 6.60% | 17.48% | 15.97% | 13.75% |
| Operating Income | -200.68M | -73.13M | -4.00M | -46.55M | 78.46M | 46.54M | 31.41M | 64.11M | 4.24M | 16.89M | -2.70M | -9.02M | 9.56M | 79.60M | 47.01M | -228.03M | -237.47M | 40.35M | 27.78M | -2.76M | 31.40M | -158.40M | -627.82M | -43.90M | 17.42M | -8.30M | -21.70M | 1.00M | 13.00M | 6.60M | 2.50M |
| Operating Income Ratio | -30.58% | -11.00% | -0.72% | -9.06% | 8.74% | 5.95% | 4.97% | 9.25% | 0.76% | 3.06% | -0.56% | -2.00% | 1.84% | 11.57% | 7.93% | -104.26% | -45.11% | 5.43% | 4.01% | -0.60% | 5.82% | -46.10% | -206.35% | -11.50% | 5.43% | -7.99% | -21.72% | 1.16% | 14.38% | 14.44% | 10.42% |
| Total Other Income/Expenses | 33.36M | 42.69M | 14.80M | -17.88M | -5.17M | 48.70M | -10.94M | 46.69M | -284.00K | 925.00K | 1.00M | -9.12M | 1.86M | 47.98M | 9.06M | 1.11M | 1.32M | 15.29M | -3.72M | 12.00K | -5.42M | -22.24M | 680.00K | 7.81M | 8.36M | -2.50M | -2.50M | -700.00K | 200.00K | 100.00K | -300.00K |
| Income Before Tax | -167.32M | -30.43M | -9.94M | -48.97M | 74.97M | 9.94M | 20.47M | 65.37M | 3.95M | 17.82M | -1.70M | -6.76M | 11.42M | 127.58M | 56.06M | -226.92M | -236.15M | 55.64M | 29.91M | -1.20M | 25.99M | -180.85M | -627.41M | -36.10M | 25.51M | -8.90M | -22.70M | 400.00K | 13.00M | 6.70M | 2.20M |
| Income Before Tax Ratio | -25.49% | -4.58% | -1.79% | -9.53% | 8.36% | 1.27% | 3.24% | 9.43% | 0.71% | 3.22% | -0.35% | -1.50% | 2.20% | 18.54% | 9.45% | -103.75% | -44.86% | 7.49% | 4.32% | -0.26% | 4.81% | -52.63% | -206.21% | -9.46% | 7.94% | -8.57% | -22.72% | 0.46% | 14.38% | 14.66% | 9.17% |
| Income Tax Expense | -3.15M | -17.55M | 1.35M | -20.10M | 9.94M | 50.00K | -47.25M | 12.14M | 75.81M | 3.43M | -1.98M | -2.17M | 123.28M | 1.95M | -2.75M | 643.00K | 1.23M | 2.29M | 4.73M | 5.20M | 8.05M | 4.91M | 92.82M | -6.44M | 12.75M | -1.00M | -4.30M | -400.00K | 4.50M | 2.10M | 700.00K |
| Net Income | -164.17M | -14.26M | -11.29M | -28.87M | 64.85M | 9.89M | 116.58M | 62.61M | -69.48M | 14.22M | 31.36M | -2.22M | 136.79M | 128.35M | 58.98M | -227.86M | -235.95M | 151.47M | 25.93M | -10.06M | 17.72M | -185.76M | -719.95M | -29.66M | 12.75M | -7.90M | -18.40M | 800.00K | 8.50M | 4.60M | 1.50M |
| Net Income Ratio | -25.01% | -2.14% | -2.03% | -5.62% | 7.23% | 1.26% | 18.46% | 9.04% | -12.40% | 2.57% | 6.50% | -0.49% | 26.33% | 18.65% | 9.95% | -104.18% | -44.83% | 20.38% | 3.74% | -2.17% | 3.28% | -54.06% | -236.63% | -7.77% | 3.97% | -7.60% | -18.42% | 0.93% | 9.40% | 10.07% | 6.25% |
| EPS | -3.09 | -0.22 | -0.15 | -0.39 | 0.88 | 0.14 | 1.65 | 0.90 | -1.02 | 0.21 | 0.47 | -0.03 | 2.10 | 2.02 | 0.94 | -3.62 | -3.66 | 2.06 | 0.36 | -0.22 | 0.41 | -5.05 | -27.90 | -1.65 | 0.96 | -0.71 | -1.78 | -0.66 | 1.06 | 0.72 | 0.32 |
| EPS Diluted | -3.09 | -0.22 | -0.15 | -0.39 | 0.88 | 0.14 | 1.64 | 0.89 | -1.01 | 0.21 | 0.46 | -0.03 | 2.08 | 2.01 | 0.93 | -3.62 | -3.66 | 2.04 | 0.36 | -0.22 | 0.41 | -5.05 | -27.90 | -1.65 | 0.88 | -0.71 | -1.78 | -0.66 | 0.94 | 0.72 | 0.32 |
| Weighted Avg Shares Out | 53.18M | 66.25M | 74.90M | 74.23M | 73.56M | 71.99M | 70.49M | 69.58M | 68.37M | 67.41M | 66.65M | 65.26M | 65.13M | 64.55M | 63.78M | 62.91M | 64.54M | 73.49M | 72.32M | 44.92M | 43.01M | 36.77M | 25.81M | 18.02M | 15.66M | 11.19M | 10.34M | 7.88M | 7.64M | 6.39M | 4.69M |
| Weighted Avg Shares Out (Dil) | 53.18M | 66.25M | 74.90M | 74.46M | 73.85M | 72.39M | 70.94M | 70.49M | 68.51M | 68.55M | 67.64M | 65.91M | 65.72M | 65.00M | 64.17M | 62.91M | 64.54M | 74.07M | 72.53M | 44.92M | 43.47M | 36.77M | 25.81M | 18.02M | 17.19M | 11.19M | 10.34M | 7.88M | 8.62M | 6.39M | 4.69M |
Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600
NEW YORK , Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap...
Azenta to Participate in Stephens Annual Investment Conference
BURLINGTON, Mass. , Nov. 14, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that Company management will participate in Stephens Annual Investment Conference, on Wednesday November 20, 2024, which includes a presentation beginning at 1:00 pm CT.
Azenta, Inc. (AZTA) Q4 2024 Earnings Call Transcript
Azenta, Inc. (NASDAQ:AZTA ) Q4 2024 Earnings Conference Call November 12, 2024 4:30 PM ET Company Participants Yvonne Perron - Vice President, FP&A and Investor Relations John Marotta - President and Chief Executive Officer Herman Cueto - Executive Vice President...
Azenta (AZTA) Q4 Earnings Top Estimates
Azenta (AZTA) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.11 per share. This compares to earnings of $0.13 per share a year ago.
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
FY'24 revenue growth of 4%, reported and organic, in combined Sample Management Solutions and Multiomics FY'25 organic revenue growth expected to be 3% to 5% year over year, with Adjusted EBITDA margin expansion of approximately 300 basis points Pursuing a...
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast
BURLINGTON, Mass. , Nov. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) will announce fiscal fourth quarter and full year 2024 earnings which ended on September 30, 2024, on Tuesday, November 12, 2024, after the market closes.
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test
BURLINGTON, Mass. , Oct. 30, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the launch of a long-read Whole Genome Sequencing (WGS) test for clinical applications.
AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO
Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass. , Sept. 4, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) ("Azenta" or "the Company"), today announced that John P.
GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event
BURLINGTON, Mass. , Aug. 12, 2024 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced that GENEWIZ Multiomics and Synthesis Solutions from Azenta Life Sciences will be hosting its 25th anniversary and the launch of its annual GENEWIZ Week event on...
Azenta, Inc. (AZTA) Q3 2024 Earnings Call Transcript
Azenta, Inc. (NASDAQ:AZTA ) Q3 2024 Results Conference Call August 6, 2024 4:30 PM ET Company Participants Yvonne Perron - Vice President, FP&A and Investor Relations Steve Schwartz - President and Chief Executive Officer Herman Cueto - Chief Financial Officer...
Source: https://incomestatements.info
Category: Stock Reports